Key Points The big drugmaker unveiled its latest set of quarterly figures. Thanks to healthy rises in sales of key drugs, its revenue and profitability rose admirably. 10 stocks we like better than Teva Pharmaceutical Industries › Teva Pharmaceutical Industries (NYSE: TEVA) had a day on the stock market to remember on Wednesday. The drugmaker's share price enjoyed a nearly 21% rise on the day, thanks mostly to a very well-received quarterly earnings report. That increase was far more powerful than t ...